Back

mr. L.M. (Kenneth) Asselt

mr. L.M. (Kenneth) Asselt

Associate Professor

Show full profile

Research Output (164)

Relevance of Breast Cancer Subtypes in Response Monitoring with 18F-FDG PET/CT During Neoadjuvant Chemotherapy

Koolen B. B., Pengel K. E., Wesseling J., Vogel W. V., Vrancken Peeters M-J T., Gilhuijs K. G., Rutgers E. J., Valdes Olmos R. A. Mar 2012, In: European Journal of Cancer. 48 , p. S42-S42

TH‐C‐213AB‐07:Extending the Webb‐Nahum Tumour Control Probability Model for Breast Conserving Therapy

Chen W., Gilhuijs K., Stroom J., Sonke J‐j 1 Jan 2012, In: Medical Physics. 39 , p. 3994-3995 2 p.

MICROSCOPIC DISEASE EXTENSION IN THREE DIMENSIONS FOR NON-SMALL-CELL LUNG CANCER: DEVELOPMENT OF A PREDICTION MODEL USING PATHOLOGY-VALIDATED POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY FEATURES

van Loon Judith, Siedschlag Christian, Stroom Joep, Blauwgeers Hans, van Suylen Robert-Jan, Knegjens Joost, Rossi Maddalena, van Baardwijk Angela, Boersma Liesbeth, Klomp Houke, Vogel Wouter, Burgers Sjaak, Gilhuijs Kenneth Jan 2012, In: International Journal of Radiation Oncology Biology Physics. 82 , p. 448-456

Impact of negative margin width on local recurrence in breast conserving therapy

Chen W., Stroom J., Sonke J.J., Bartelink H., Schmitz A.C., Gilhuijs K.G.A. 2012, In: Radiotherapy & Oncology. 104 , p. 148-154 7 p.

Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: Potential relevance for MRI-guided localized therapy

Schmitz A.C., Pengel K.E., Loo C.E., van den Bosch M.A.A.J., Wesseling J., Gertenbach M., Alderliesten T., Mali W.P.T.M., Rutgers E.J.T., Bartelink H., Gilhuijs K.G.A. 2012, In: Radiotherapy & Oncology. 104 , p. 11-18 8 p.

Relevance of Magnetic Resonance Imaging To Predict Disease-Free Survival after Neoadjuvant Chemotherapy of Breast Cancer.

Loo C. E., Vrancken Peeters M-J T. F. D., Wesseling J., Gilhuijs K. G. A. 15 Dec 2011, In: Cancer Research. 71

Combined Use of 18F-FDG PET/CT and MRI To Monitor Breast Cancer Response during Neoadjuvant Chemotherapy.

Pengel K. E., Koolen B. B., Vogel W., Valdes Olmos R., Wesseling J., Vrancken Peeters M-J, Loo C. E., Gilhuijs K. G. 15 Dec 2011, In: Cancer Research. 71

Computer-Derived Breast MRI Features Have Complementary Value for Preoperative Selection of Systemic Drug Therapy in Node-Negative Stage-I/II Breast Cancer Patients.

Gilhuijs K. G. A., Pengel K. E., Dmitriev I., Paape A., Rutgers E. E. J. T. H., Wesseling J., Loo C. E. 15 Dec 2011, In: Cancer Research. 71

Excised and irradiated volumes in relation to the tumor size in breast-conserving therapy

den Hartogh M.D., van Asselen B., Monninkhof E.M., van den Bosch M.A.A.J., van Vulpen M., van Diest P.J., Gilhuijs K.G.A., Witkamp A.J., van de Bunt L., Mali W.P.T.M., van den Bongard H.J.G.D. Oct 2011, In: Breast Cancer Research and Treatment. 129 , p. 857-865

Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype

Loo C.E., Straver M.E., Rodenhuis S, Muller S.H., Wesseling J., Vrancken Peeters M.J., Gilhuijs K.G.A. 2011, In: Journal of Clinical Oncology. 29 , p. 660-666 7 p.

Thank you for your review!

Has this information helped you?
Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not